← SynDRA
SYN0718173
SynDRA canonical compound SYN0718173 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EIF2A |
|---|
| Mechanism of action | eukaryotic translation initiation factor inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Sal003
- RefChem:396584
- SMR000184519
- MLS000573670
- SAL-003
- C18H15Cl4N3OS
- MFCD00361095
- orb1305512
- SCHEMBL17748150
- BDBM57469
- cid_5717737
- eIF-2? Inhibitor II, Sal003
- GLXC-05929
- HMS2374J18
- HMS3414E09
- HMS3678E09
- HMS3886L15
- BMA35991
- EX-A2152
- PWB47053
- s7437
- STL253109
- AKOS002338493
- AKOS016336084
- CCG-269375
- CS-4190
- Sal003, >=98% (HPLC)
- AC-35950
- BS-14375
- HY-15969
- C71536
- F865528
- BRD-A45869167-001-10-0
- BRD-A45869167-001-11-8
Look up SYN0718173 in the interactive SynDRA portal →